Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

June 20, 2023

Study Completion Date

July 28, 2023

Conditions

Exocrine Pancreatic InsufficiencyCystic Fibrosis

Interventions

DRUG

adrulipase

Enteric microgranule formulation of adrulipase.

Trial Locations (3)

Central Florida Pulmonary Group, Orlando

The Cystic Fibrosis Institute, Northfield

Childrens Lung Specialists, Las Vegas